Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
18.22
+0.78 (4.47%)
At close: Oct 15, 2026, 4:00 PM EDT
18.22
0.00 (0.00%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Viatris Employees
Viatris had 30,000 employees as of December 31, 2025. The number of employees decreased by 2,000 or -6.25% compared to the previous year. That makes Viatris the 1,242nd largest employer in the world and 324th in the United States.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$491,243
Profits / Employee
-$13,690
Market Cap
20.93B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
VTRS News
- 7 days ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pacira BioSciences, Inc. (PCRX) - Newsfile Corp
- 7 days ago - Pacira upgraded to Neutral from Underweight at JPMorgan - TheFly
- 7 days ago - Viatris to Buy Pacira BioSciences for $1.65 Billion - WSJ
- 7 days ago - Viatris: Pacira deal expected to be immediately accretive to financial guidance - TheFly
- 7 days ago - Viatris to acquire Pacira for $36.50 per share in cash, or $1.65B - TheFly
- 7 days ago - Viatris to acquire Pacira for $36.50 per share in cash, or $1.65B - TheFly
- 7 days ago - Viatris to buy pain therapy maker Pacira Biosciences for $1.65 billion - Reuters
- 7 days ago - Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies - PRNewsWire